StonvexLoading…
StonvexStonvexStonvexCore line items from ST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.70B | $3.93B | $4.05B | $4.03B |
Operating Income | $237.50M | $149.30M | $181.70M | $670.14M |
Net Income | $31.30M | $128.50M | $-3.90M | $310.69M |
EPS (Diluted) | $0.21 | $0.85 | $-0.03 | $1.99 |
Total Assets | $6.75B | $7.14B | $7.68B | $8.76B |
Total Liabilities | $3.97B | $4.25B | $4.68B | $5.65B |
Cash & Equivalents | $573.00M | $593.70M | $508.10M | $1.23B |
Free Cash Flow OCF − CapEx | $490.30M | $392.90M | $272.10M | $310.53M |
Shares Outstanding | 147.10M | 150.70M | 152.10M | 155.93M |